VIEW THE PRESENTATION
Presentation Description:
Clinical trials remain the most critical tool to improve outcome in paediatric cancer. This workshop will review current regulatory and ethics regulations and preview the upcoming roll out of the Ontario Cancer Research Ethics Board (OCREB) to satellite care. Interactive case discussions will highlight important elements of reporting adverse events that occur on study. Furthermore, the session will include a preview of a variety of upcoming OCREB trials and an open discussion of research challenges in the satellite context.
Speakers:
Sarah Alexander, MD
Clinical Director, Haematology/Oncology, The Hospital for Sick Children, Toronto, ON
Sarah Alexander is the clinical director of the Division of Haematology/ Oncology at SickKids. She is a member of the leukemia and lymphoma section. Her research is focused on infectious complications of chemotherapy and strategies for the treatment of children with non-Hodgkin lymphoma. She has been working with POGO, OCREB and leads from the other centres on optimizing the system for regulatory compliance and REB oversight for patients enrolled on clinical trials who receive care at tertiary and satellite centres.
Paul Gibson, MD, FRCPC
Pediatric Oncologist, Children’s Hospital, London Health Sciences Centre (LHSC), London, ON
Medical Officer, Pediatric Oncology Group of Ontario
Assistant Professor, Western University, London, ON
Paul Gibson is a graduate of Queen’s University’s Medical School. He completed pediatric residency training at B.C. Children’s Hospital prior to subspecialty training at The Hospital for Sick Children. He joined the Section of Pediatric Haematology and Oncology at Children’s Hospital full time in 2010. He has served as Physician Lead in the LHSC Computerized Provider Order Entry and PowerChart Oncology projects. Dr. Gibson has served as Medical Officer of the Pediatric Oncology Group of Ontario (POGO) since 2015. His role with POGO includes medical support of the POGO Satellite program and a member of the executive oversight committee of the provincial pediatric oncology planning process.